Analogic Corporation (NASDAQ:ALOG) Files An 8-K Regulation FD Disclosure

0

Analogic Corporation (NASDAQ:ALOG) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure

Attached as Exhibit 99.1, and furnished for purposes of Regulation FD, is an investor presentation to be given by Analogic Corporation at investor meetings to be held in connection with the JP Morgan Healthcare Investor Conference on January11, 2018.

The information in this Current Report on Form 8-K (including Exhibit99.1) is being furnished to Item 7.01 and shall not be deemed to be “filed” for purposes of Section18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act. The information set forth in this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 7.01 Financial Statements and Exhibits

(d) The following exhibit is furnished, and not filed:

Exhibit

No.

Description
99.1 Analogic Corporation Investor Presentation


ANALOGIC CORP Exhibit
EX-99.1 2 d518915dex991.htm EX-99.1 EX-99.1 50 years of imaging innovation 36th Annual JP Morgan Healthcare conference Fred parks,…
To view the full exhibit click here

About Analogic Corporation (NASDAQ:ALOG)

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.